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Ovarian-type surface epithelial neoplasms of the testis and paratestis are uncommon, and the mucinous subtype is particularly
rare. These tumors represent a counterpart to ovarian cancer. Malignant tumors have the potential for metastatic spread and are
oftenfatal.Thecaseofa59-year-oldmanwithtesticularmucinousadenocarcinomaispresented.Computedtomographyindicated
involvement of the paraaortic and pelvic lymph nodes, so chemotherapy was initiated. To the best of our knowledge, this is the
second paper regarding responsiveness to chemotherapies used in ovarian cancer.
1.Introduction
Primary ovarian-type surface epithelial carcinomas of the
testis and paratestis are very rare [1]. The mucinous subtype
is particularly rare, with only 20 cases reported to date [2–6].
We report a case of primary mucinous adenocarcinoma
of the testis with retroperitoneal metastasis. We discuss the
management of this uncommon testicular tumor based on
the limited reports.
2.CaseReport
A 59-year-old man with hyperlipidemia presented with a
2-month history of right testicular discomfort and painless
swelling. Physical examination revealed a ﬁrm mass with an
irregular surface in the right scrotum. No lymphadenopathy
was palpable. Laboratory ﬁndings showed elevation of
serum carbohydrate antigen 19-9 (CA19-9) to 17,200U/mL
(normal, <37U/mL) and carcinoembryonic antigen (CEA)
to 6.5ng/mL (normal, <5ng/mL), although levels were
normal for serum germ cell tumor markers such as lactate
dehydrogenase (LDH), β-human chorionic gonadotropin
(β-hCG), and α-fetoprotein (AFP). Transscrotal ultrasonog-
raphyshoweda6 ×4 ×2cmmasswithcystintherighttestis.
Abdominal computed tomography (CT) revealed swelling
of the paraaortic and pelvic lymph nodes to a diameter
of 2.5cm (Figure 1). Chest radiography showed no normal
abnormalities. No gastrointestinal tumor was indicated on
upper and lower gastrointestinal endoscopy.
Right primary testicular tumor was diagnosed and the
patient underwent right inguinal orchiectomy. Pathological
examination demonstrated that the tumor consisted of solid
tumor containing mucinous ﬂuid. Microscopically, a single
or several layers of columnar epithelium producing mucin
showed papillary growth. The tumor epithelium exhibited
stromal invasion (Figure 2). No teratomatous element, germ
cell neoplasia, or ovarian-type stroma was evident.
After orchiectomy, serum CA19-9 fell to 6,860U/mL.
Adjuvant chemotherapy was initiated to treat paraaortic
lymph node metastasis using paclitaxel (185mg/m2)a n d
carboplatin (AUC 6) administered every 3 weeks for a total
of three cycles. After the ﬁrst treatment, the level of CA19-
9 halved but subsequently increased to 10,270U/mL for the
next two cycles. Multiple lung and liver metastases were
identiﬁed on CT at this time. These ﬁndings suggested that
the tumor had developed resistance to the ﬁrst regimen.
The patient decided against further treatment and died 10
months later.
3. Discussion
Primary ovarian-type surface epithelial carcinomas of the
testis and paratestis are rare [1]. Six subtypes have been
deﬁned: serous, mucinous, endometrioid, clear, transitional,2 Case Reports in Medicine
Figure 1: Computed tomography revealing metastases in pelvic
lymph nodes.
(a)
(b)
Figure 2: Microscopic ﬁndings (hematoxylin and eosin) showing
mucinous adenocarcinoma. Single or multiple layers of columnar
epithelium with mucin are visible. In some portions, papillary
growth was also observed. (a) 40x; (b) 200x.
and squamous. The most frequent of these is the serous
subtype, while the mucinous subtype is very rare. To the
best of our knowledge, only 20 cases (including the present
case) have been reported to date [2–6]. The incidence of
these tumors is higher among older age groups than that
of common testicular tumors, with a median age at onset
of 54 years [2–6]. Similar to ovarian tumors, the biological
behaviorrangesfrombenigntoborderlinetomalignantwith
metastasis. Although the gross features resemble the well-
known ovarian tumors, a few diﬀerences are worth noting.
Testicular tumors are not generally as large as the ovarian
ones, as the more conspicuous location results in patients
seeking attention earlier. As a result, the chief complaint
is commonly painless enlargement of the testis, sometimes
with a hydrocele. Compared to an ovarian tumor, a testicular
tumor is more often a unilocular cystic tumor.
The most important diﬀerential diagnosis is metastasis
from the gastrointestinal tract for primary ovarian-type sur-
face epithelial carcinomas of the testis. In cases with ovari-
an tumors, immunostaining for cytokeratin 7, MUC2,
MUC5AC, and MUC6 has been reported to be useful in dis-
tinguishing this from metastatic ovarian tumors. Also, with
intratesticular mucinous adenocarcinoma, some reports
have suggested the utility of immunohistochemical staining
[2]. However, solid evidence is lacking, because of unavail-
able material. The possibility of metastatic lesions from pri-
mary tumors of other primary sites should thus be excluded
by appropriate clinical, endoscopic, and radiographic inves-
tigations.
The standard treatment for localized disease is radical
orchiectomy. The signiﬁcance of adjuvant chemotherapy re-
mains controversial, as most reported cases have not shown
metastases and have enjoyed a good prognosis. Our case dis-
played a metastasis at the time of ﬁrst diagnosis of testicular
tumor, and the tumor behaved in a positively malignant
manner. We selected paclitaxel and carboplatin administered
every 3 weeks as adjuvant chemotherapy, as used for ﬁrst-
line chemotherapy in ovarian cancer [7]. The tumor was
initially sensitive to this regimen but became resistant after
3 cycles. The second-line agent for relapsed ovarian cancer
is liposomal doxorubicin or gemcitabine. The patient desired
palliative care and died 10 months after ending chemother-
apy.
In conclusion, our case showed two important points.
The ﬁrst point is that we should take into consideration
that this type of tumor might have malignant potential,
although most previous reports have shown the features of
a favorable clinical outcome. Second, experience is limited
with intratesticular mucinous adenocarcinoma. However, its
behavior appears similar to that of its ovarian counterparts.
Chemotherapy with paclitaxel and carboplatin might have
potential eﬃcacy, as previously reported.
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